![]() Adocia Adocia is a clinical-stage biotechnology company that specializes in the research and development of innovative formulations of already-approved therapeutic proteins. | ![]() Vericel Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions. | ![]() Citryll Citryll is a pharmaceutical company engaged in the treatment of autoimmune and some other human diseases with the help of tACPA program | |
Founding Date | Founding Date 2005 | Founding Date 1989 | Founding Date 2019 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Lyon-3E-Arrondissement, FR HQ | Locations Cambridge, US HQ Ann Arbor, US | Locations Oss, NL HQ |
Employees | Employees 75 | Employees 24112% increase | Employees 313% increase |
Valuation ($) | Valuation ($) 158 m | Valuation ($) 2.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €1.5m (FY, 2025) | Revenue (est.) $276.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €792k (FY, 2025) | Cost of goods $70.7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €3.1m (FY, 2025) | Gross profit $205.6m (FY, 2025) | Gross profit N/A |
Net income | Net income (€16.6m) (FY, 2025) | Net income $16.5m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 37m | Total funding raised N/A | Total funding raised $ 39.9m |

Vericel develops, manufactures, and markets autologous cell-based therapies for patients with serious diseases and conditions.
View company
Citryll is a pharmaceutical company engaged in the treatment of autoimmune and some other human diseases with the help of tACPA program
View company